Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the launch of UDENYCA ONBODY™, the company’s on-body …
New Drug Application of Mabwell’s 8MW0511 for Injection Accepted by NMPA
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug …
